Filtros de búsqueda

Lista de obras de Stefano Luminari

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.

artículo científico publicado en 2018

A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients

artículo científico publicado en 2019

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.

artículo científico publicado en 2014

A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias

scientific article published on 01 May 2008

A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma.

artículo científico publicado en 2015

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

artículo científico publicado en 2009

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

artículo científico publicado en 2016

Addition of Rituximab to Front-Line-Treatment Highly Improved the Outcome of Elderly Patients with Follicular Lymphoma: a Population Based-Study From the Modena Cancer Registry ⬇️

scholarly article

Advances in Treatment of Follicular Lymphoma

artículo científico publicado en 2020

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients

artículo científico publicado en 2016

Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma

artículo científico publicado en 2009

Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma

artículo científico publicado en 2011

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

artículo científico publicado en 2014

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

artículo científico publicado en 2016

Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies ⬇️

artículo científico publicado en 2015

Bendamustine Salvage Therapy for T-Cell Non Hodgkin Lymphoma ⬇️

scholarly article

Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09) ⬇️

artículo científico publicado en 2013

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

artículo científico publicado en 2014

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

artículo científico publicado en 2016

Bendamustine salvage therapy for T cell neoplasms

artículo científico publicado en 2013

Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

artículo científico publicado en 2007

Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time.

artículo científico publicado en 2009

Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).

artículo científico publicado en 2002

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

scientific article published on 08 July 2019

Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.

artículo científico publicado en 2009

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

artículo científico publicado en 2015

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

artículo científico publicado en 2013

Bridging the gap between epidemiology and clinical research in lymphoma

artículo científico publicado en 2013

CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11)

Cancer incidence in people with AIDS in Italy

article

Case studies of elderly patients with non-Hodgkin's lymphoma.

artículo científico publicado en 2011

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).

artículo científico publicado en 2010

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative. ⬇️

artículo científico publicado en 2009

Curative intent therapy for DLBCL in the elderly

artículo científico publicado en 2024

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the

scientific article published on 15 November 2011

Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas.

artículo científico publicado en 2009

Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry

artículo científico publicado en 2014

Droplet digital PCR is a sensitive tool for the detection of TP53 deletions and point mutations in chronic lymphocytic leukaemia

artículo científico publicado en 2020

Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy.

artículo científico publicado en 2016

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2018

Early Response to a Short Course of Induction Chemotherapy Overcomes the Prognostic Role of IPI in Patients with Aggressive NHL. Preliminary Results of the GISL LA05 Trial. ⬇️

scholarly article

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

artículo científico publicado en 2007

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

artículo científico publicado en 2019

Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.

artículo científico publicado en 2005

Fertility in female survivors of Hodgkin's lymphoma.

artículo científico publicado en 2012

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

artículo científico publicado en 2020

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

scientific article published on 25 July 2019

Follicular lymphoma - treatment and prognostic factors

artículo científico publicado en 2012

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

artículo científico publicado en 2009

GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion

artículo científico publicado en 2010

Gene expression profile unveils diverse biological effect of serum VitaminD in Hodgkin's and Diffuse Large B-Cell Lymphoma

scientific article published on 20 November 2020

Germinotropic lymphoproliferative disorder: a systematic review

scientific article published on 19 April 2020

Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial

artículo científico publicado en 2012

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s

artículo científico publicado en 2011

High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results.

artículo científico publicado en 2008

High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.

artículo científico publicado en 2003

Home Care of Acute Leukemia Patients: From Active Therapy to End-of-Life and Palliative Care. a Three-Year Experience of a Single Centre ⬇️

scholarly article

Home care of acute leukaemia patients: From active therapy to end-of-life and palliative care. The 3-year experience of a single centre

scientific article published on 15 March 2019

Identification of a Novel Gene Expression Signature in Mantle Cell Lymphoma from the Fondazione Italiana Linfomi (FIL)-MCL-0208 Trial: A Focus on the B Cell Receptor Pathway ⬇️

artículo científico publicado en 2015

Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.

artículo científico publicado en 2005

Incidence Clinical Characteristics and Survival of Non Splenic Marginal Zone Lymphomas: A Population Based Study from a Cancer Registry in Northern Italy ⬇️

scholarly article

Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy

artículo científico publicado en 2007

Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients

artículo científico publicado en 2007

Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas

artículo científico publicado en 2017

Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).

artículo científico publicado en 2012

Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.

artículo científico publicado en 2010

Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2007

Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2014

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

artículo científico publicado en 2017

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.

artículo científico publicado en 2015

Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi

artículo científico publicado en 2011

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

artículo científico publicado en 2005

Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma

scientific article published on 14 May 2020

Low Toxicity Profile of the Combination of Bendamustine Plus Rituximab (BR) in Elderly FRAIL Patients with Newly Diagnosed DLBCL ⬇️

artículo científico publicado en 2014

Low-grade MALT lymphoma involving multiple mucosal sites and bone marrow

artículo científico publicado en 1998

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients

artículo científico publicado en 2014

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial

artículo científico publicado en 2014

Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas

artículo científico publicado en 2013

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients ⬇️

scholarly article

Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes.

artículo científico publicado en 2001

Non-peghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity

artículo científico publicado en 2020

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.

artículo científico publicado en 2017

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi

artículo científico publicado en 2019

Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results From a Study of the Intergruppo Italiano Linfomi (IIL) ⬇️

scholarly article

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

artículo científico publicado en 2013

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

artículo científico publicado en 2013

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

artículo científico publicado en 2016

PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).

artículo científico publicado en 2016

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2015

Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.

artículo científico publicado en 2014

Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL).

artículo científico publicado en 2010

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

scientific article published on 26 November 2018

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

artículo científico publicado en 2015

Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"?

artículo científico publicado en 2015

Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

artículo científico publicado en 2020

Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi ⬇️

scholarly article

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL). ⬇️

scholarly article

Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias

artículo científico publicado en 2003

Prognosis of follicular lymphomas

scientific article published on 01 June 2006

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients. ⬇️

artículo científico publicado en 2010

Prognostic Role of Serum Albumin Level in DLBCL before and during the Rituximab Era. Retrospective GISL Study over 738 Cases ⬇️

artículo científico publicado en 2014

Prognostic Score Based on Clinical and Biochemical Surrogates of Disease Status in DLBCL Trated with Chemo-Immunotherapy ⬇️

artículo científico publicado en 2014

Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.

artículo científico publicado en 2017

Prognostic assessment in patients with indolent B-cell lymphomas.

artículo científico publicado en 2012

Prognostic factors in low-grade non-Hodgkin lymphomas

scientific article published on October 2009

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

artículo científico publicado en 2018

Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.

artículo científico publicado en 2007

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study

artículo científico publicado en 2012

Prognostic tools in follicular lymphomas

artículo científico publicado en 2009

Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies

artículo científico publicado en 2014

Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy.

artículo científico publicado en 2002

Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi

artículo científico publicado en 2004

R-CHOP vs R-mini-CEOP in Elderly Patients with Diffuse Large B Cell Lymphoma: An Interim Report from Intergruppo Italiano Linfomi (IIL). ⬇️

artículo científico publicado en 2005

R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi

artículo científico publicado en 2013

Renewed interest for low-dose radiation therapy in follicular lymphomas: From biology to clinical applications

artículo científico publicado en 2018

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Reply to T.P. Vassilakopoulos et al.

artículo científico publicado en 2016

Report of the 6th International Workshop on PET in lymphoma

artículo científico publicado en 2017

Report on the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

artículo científico publicado en 2015

Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.

artículo científico publicado en 2009

Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.

artículo científico publicado en 2012

Rituximab (R) in Combination with Fludarabine (F) and Cyclophosphamide (C) in Relapsed Follicular Lymphoma (FL) Patients (pts).Final Results of FC + R Phase II Trial by the GISL. ⬇️

scholarly article

Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

artículo científico publicado en 2018

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

artículo científico publicado en 2011

Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

artículo científico publicado en 2015

Role Of Interim,-PET In Poor Prognosis Young Patients With Diffuse Large B Cell Lymphoma At Diagnosis: Data From An Ancillary Study Of a Prospective Randomized Phase III Study (DLCL04) From the Fondazione Italiana Linfomi ⬇️

artículo científico publicado en 2013

Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.

artículo científico publicado en 2012

Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.

artículo científico publicado en 2012

Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study

artículo científico publicado en 2017

Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.

artículo científico publicado en 2015

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.

artículo científico publicado en 2008

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.

artículo científico publicado en 2017

Splenosis peritonei

artículo científico publicado en 2003

Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi

artículo científico publicado en 2020

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project

artículo científico publicado en 2011

Survival of cancer patients in Italy

artículo científico publicado en 2017

Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.

artículo científico publicado en 2013

T-cell lymphomas in South america and europe

artículo científico publicado en 2012

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma

artículo científico publicado en 2021

Texture analysis and multiple-instance learning for the classification of malignant lymphomas

artículo científico publicado en 2019

The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).

artículo científico publicado en 2016

The Elderly Project By the Fondazione Italiana Linfomi (FIL): A Prospective Multidimensional Assessment of Elderly Patients with Diffuse Large B-Cell Lymphoma ⬇️

artículo científico publicado en 2016

The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry

The Role Of Qualitative FDG-PET Assessment Using The 5 Point Deauville Scale For Postinduction Response Assessment In Patients With Follicular Lymphoma. A Study From The Fondazione Italiana Linfomi (FIL) ⬇️

artículo científico publicado en 2013

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study.

artículo científico publicado en 2015

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study

artículo científico publicado en 2018

The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study.

artículo científico publicado en 2006

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

artículo científico publicado en 2014

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

artículo científico publicado en 2006

The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).

artículo científico publicado en 2014

The role of anthracyclines in follicular lymphomas

artículo científico publicado en 2006

The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).

artículo científico publicado en 2006

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

artículo científico publicado en 2006

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2013

The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.

artículo científico publicado en 2014

Transformed follicular lymphoma.

artículo científico publicado en 2017

Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.

artículo científico publicado en 2003

Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.

artículo científico publicado en 2012

Use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy.

artículo científico publicado en 2011

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

artículo científico publicado en 2015

Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group

artículo científico publicado en 2016

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

scientific article published on 27 July 2006

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi

artículo científico publicado en 2006

Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database

artículo científico publicado en 2012

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda